AU560170B2 - 4-aminoalkyl-2(3h)-indolones - Google Patents

4-aminoalkyl-2(3h)-indolones

Info

Publication number
AU560170B2
AU560170B2 AU21585/83A AU2158583A AU560170B2 AU 560170 B2 AU560170 B2 AU 560170B2 AU 21585/83 A AU21585/83 A AU 21585/83A AU 2158583 A AU2158583 A AU 2158583A AU 560170 B2 AU560170 B2 AU 560170B2
Authority
AU
Australia
Prior art keywords
indolones
aminoalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU21585/83A
Other languages
English (en)
Other versions
AU2158583A (en
Inventor
Gregory Gallagher Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23776840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU560170(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2158583A publication Critical patent/AU2158583A/en
Application granted granted Critical
Publication of AU560170B2 publication Critical patent/AU560170B2/en
Assigned to SMITHKLINE BEECHAM CORPORATION reassignment SMITHKLINE BEECHAM CORPORATION Request to Amend Deed and Register Assignors: SMITHKLINE BECKMAN CORPORATION
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU21585/83A 1982-12-07 1983-11-22 4-aminoalkyl-2(3h)-indolones Expired AU560170B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/447,564 US4452808A (en) 1982-12-07 1982-12-07 4-Aminoalkyl-2(3H)-indolones
US447564 1982-12-07

Publications (2)

Publication Number Publication Date
AU2158583A AU2158583A (en) 1984-06-14
AU560170B2 true AU560170B2 (en) 1987-04-02

Family

ID=23776840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21585/83A Expired AU560170B2 (en) 1982-12-07 1983-11-22 4-aminoalkyl-2(3h)-indolones

Country Status (27)

Country Link
US (1) US4452808A (enExample)
EP (1) EP0113964B1 (enExample)
JP (1) JPS59112964A (enExample)
KR (1) KR910001042B1 (enExample)
AU (1) AU560170B2 (enExample)
BR (1) BR1100036A (enExample)
CA (1) CA1208650A (enExample)
CY (1) CY1497A (enExample)
CZ (1) CZ398191A3 (enExample)
DE (1) DE3367090D1 (enExample)
DK (1) DK156514C (enExample)
DZ (1) DZ587A1 (enExample)
EG (1) EG16556A (enExample)
ES (2) ES527827A0 (enExample)
FI (1) FI77849C (enExample)
GR (1) GR79121B (enExample)
HK (1) HK82089A (enExample)
IE (1) IE56347B1 (enExample)
IL (1) IL70311A (enExample)
LU (1) LU90097I2 (enExample)
NL (1) NL970005I2 (enExample)
NO (2) NO160135C (enExample)
NZ (1) NZ206344A (enExample)
PH (1) PH22067A (enExample)
PT (1) PT77739B (enExample)
ZA (1) ZA839094B (enExample)
ZW (1) ZW25883A1 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
GB8621040D0 (en) * 1986-08-30 1986-10-08 Smith Kline French Lab Process
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
JPH07506823A (ja) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 記憶障害，性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
JP2000516959A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション ４―アミノエトキシインドロン誘導体
AR014847A1 (es) * 1998-04-13 2001-03-28 American Home Prod 4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
FR2821843B1 (fr) * 2001-03-12 2003-05-09 Servier Lab Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
WO2004024163A1 (en) * 2002-09-13 2004-03-25 Motac Neuroscience Limited Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines
AU2003267557B2 (en) * 2002-09-17 2009-02-26 Motac Neuroscience Limited Treatment of dyskinesia
ES2237307B1 (es) * 2003-10-14 2006-11-01 Urquima, S.A. Procedimiento para la preparacion de ropinirol.
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
JP2007537226A (ja) * 2004-05-11 2007-12-20 エギシュ ヂョヂセルヂャール エンニュ・エル・テー アルキルオキシンドールのピペラジン誘導体
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法
WO2007010557A2 (en) * 2005-07-22 2007-01-25 Ind-Swift Laboratorie Limted Process for the preparation of highly pure ropinirole
ATE517865T1 (de) 2006-03-29 2011-08-15 Alembic Ltd Verfahren zur aufreinigung von ropinirolhydrochlorid
MX2008012683A (es) * 2006-04-06 2009-01-07 Nupathe Inc Implantes para el tratamiento de estados asociados con dopamina.
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN100457732C (zh) * 2006-05-25 2009-02-04 药源药物化学（上海）有限公司 罗匹尼罗的制备方法
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
EP2156833B1 (en) * 2007-05-11 2011-11-30 Santen Pharmaceutical Co., Ltd Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
US20090076124A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched ropinirole
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
US20110195117A1 (en) * 2008-09-01 2011-08-11 Lupin Limited Controlled release compositions of ropinirole
WO2010035245A2 (en) 2008-09-29 2010-04-01 Wockhardt Research Centre Extended release dosage form of ropinirole
US20100130582A1 (en) * 2008-11-24 2010-05-27 Auspex Pharmaceuticals, Inc. Indolinone modulators of dopamine receptor
CN102361638B (zh) 2009-05-21 2013-07-17 久光制药株式会社 经皮吸收制剂
EP2513055A1 (en) * 2009-12-16 2012-10-24 Pharmathen S.A. Process for the preparation of ropinirole and salts thereof
NZ602274A (en) 2010-04-30 2014-05-30 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
EP2688561B1 (en) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
KR20150059177A (ko) 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
JP6242811B2 (ja) 2012-12-10 2017-12-06 キッセイ薬品工業株式会社 新規なオクタヒドロピリドキナゾリン誘導体、それを含有する医薬組成物およびそれらの用途
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
WO2018227553A1 (zh) 2017-06-16 2018-12-20 浙江华海立诚药业有限公司 盐酸罗匹尼罗的纯化方法
CN115466209A (zh) * 2022-09-29 2022-12-13 南通大学 一种罗匹尼罗环戊烷并吲哚酮杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA895875A (en) * 1972-03-21 Bourdais Jacques Mercapto indole derivatives
US3573310A (en) * 1967-09-28 1971-03-30 Miles Lab 1-substituted derivatives of 2-indolinone
JPS5825673B2 (ja) * 1976-03-31 1983-05-28 大塚製薬株式会社 オキシインド−ル誘導体
JPS5840539B2 (ja) * 1976-03-31 1983-09-06 大塚製薬株式会社 α−置換アミノアルカノイルオキシインド−ル誘導体
JPS5919537B2 (ja) * 1976-08-02 1984-05-07 大塚製薬株式会社 オキシインド−ル誘導体
US4317944A (en) * 1980-08-15 1982-03-02 General Electric Company Preparation of 2,2-bis(4-hydroxyphenyl) propane
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones

Also Published As

Publication number Publication date
IL70311A0 (en) 1984-02-29
EP0113964A1 (en) 1984-07-25
GR79121B (enExample) 1984-10-02
AU2158583A (en) 1984-06-14
US4452808A (en) 1984-06-05
NO834485L (no) 1984-06-08
IE832866L (en) 1984-06-07
ES8604143A1 (es) 1986-01-16
NO160135B (no) 1988-12-05
DE3367090D1 (de) 1986-11-27
FI834421A0 (fi) 1983-12-02
JPH0150703B2 (enExample) 1989-10-31
EG16556A (en) 1989-01-30
FI834421L (fi) 1984-06-08
NL970005I1 (nl) 1997-04-01
CY1497A (en) 1990-02-16
DK562183D0 (da) 1983-12-06
CA1208650A (en) 1986-07-29
KR910001042B1 (ko) 1991-02-21
NO160135C (no) 1989-03-15
KR840006963A (ko) 1984-12-04
BR1100036A (pt) 2000-01-11
JPS59112964A (ja) 1984-06-29
DK562183A (da) 1984-06-08
PT77739B (en) 1986-03-27
FI77849C (fi) 1989-05-10
NL970005I2 (nl) 1997-10-01
HK82089A (en) 1989-10-20
IL70311A (en) 1986-11-30
CZ398191A3 (en) 1993-02-17
ES8600239A1 (es) 1985-10-01
EP0113964B1 (en) 1986-10-22
IE56347B1 (en) 1991-07-03
ZA839094B (en) 1985-02-27
FI77849B (fi) 1989-01-31
PT77739A (en) 1983-12-01
ZW25883A1 (en) 1984-04-18
ES527827A0 (es) 1985-10-01
DZ587A1 (fr) 2004-09-13
LU90097I2 (fr) 1997-07-16
PH22067A (en) 1988-05-20
NO1999011I1 (no) 1999-06-18
DK156514C (da) 1990-03-12
ES543593A0 (es) 1986-01-16
NZ206344A (en) 1987-03-31
DK156514B (da) 1989-09-04

Similar Documents

Publication Publication Date Title
AU560170B2 (en) 4-aminoalkyl-2(3h)-indolones
AU551215B2 (en) Curler-styler
AU1146383A (en) Amidoximeguinolines
AU1383083A (en) Ligator-clip
AU2415184A (en) Zahnreinigungsgerat
AU1115783A (en) Quadricycle
AU1112583A (en) Pyrazolo-quinolines, -thiazines and -oxazines
AU1315083A (en) Massage-douche
AU558283B2 (en) Sectionaliser
AU560471B2 (en) Electroplasmolyzer
AU1395383A (en) Benzoazacycloalkyl-spiro-imidazolidines
AU2007583A (en) Untrasonography
AU1227483A (en) Klaranlage
AU582296B2 (en) 2-thiacephems
AU1674883A (en) Interferon-epsilon
AU1089783A (en) N-benzothienylalkyl-n-alkyl-allylamines
AU2131283A (en) Sitz-bath
AU553328B2 (en) Oxazolidin-2-ones
AU1277283A (en) N-substituted-tetrahydrothiazines
AU1222883A (en) Transmissionsmekanisme
AU1305283A (en) Elevator-conveyor
AU1416683A (en) Sulphinyl - and sulphonyl - azacycloheptan - 2 - ones
AU1881883A (en) Mund- und zahnpflegevorrichtung
AU1104883A (en) Koksofenkammertur
AU1159083A (en) Selbstkassierer